STUMBL Score as a Risk Stratification Tool for Management of Blunt Chest Trauma Patients

March 26, 2024 updated by: hadeer mahmoud saber youssef, Assiut University

Assessment Of STUMBL Score (STUdy of the Management of BLunt Chest Wall Trauma) As A Risk Stratification Tool In Management Of Blunt Chest Trauma Patients In Emergency Departments: A Multicenter Study

The aim of this study is to assess validity of the STUMBL score in EGYPT for complications of blunt chest trauma without multi-trauma and immediate life-threatening injuries and identify patients at risk of in- hospital mortality or ICU admission and predict survival in both Assiut & Suez Canal University Hospitals.

Study Overview

Status

Not yet recruiting

Detailed Description

The STUMBL Score (STUdy of the Management of BLunt chest wall trauma) (also referred to as the Battle score) is a clinical prediction model that was developed and externally validated in 2014 in the UK . The purpose of the model is to assist in the clinical decision-making of patients with blunt chest wall trauma (excluding those with life-threatening injuries) in the Emergency Department (ED), through the calculation of a percentage risk of complications which in turn, provides a recommended discharge disposition. The STUMBL score includes five predictors: age at attendance, number of rib fractures, chronic lung disease, use of pre-injury anticoagulants and oxygen saturation (SpO2). This is the first score to introduce clinical variables, specifically chronic lung disease and anticoagulation, in contrast to other scores which have used anatomical variables and age alone. A huge benefit of the STUMBL score is that these variables are all routinely measured in the ED. Whilst other scores exist, the STUMBL Score is the only externally validated model with excellent predictive capabilities, that can be used for adult patients of all ages with blunt chest trauma presenting to the ED, not just a specific age group or severity of injury.

Collected data will be analyzed and tabulated by using appropriate statistical methods.

Statistical analysis will be performed by the SPSS statistical software computer program version 20 (Statistical Package for Social Science), Medcalc v.11.6.and Open Epi V.3.01.

Data will be described using mean ± standard deviation (SD) and frequencies according if they are quantitative or qualitative respectively.

Parametric tests will be used in the current study if data proved to be normally distributed.

For all statistical tests, a P value less than 0.05 will be taken to indicate a significant difference.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

All patients with blunt chest trauma satisfying inclusion criteria and does not include exclusion criteria

Description

Inclusion Criteria:

  • The present study will be conducted on patients of blunt chest trauma of both genders "without intently selected certain gender" and had 18 years old or more.

Exclusion Criteria:

  • patients <18 years of age
  • patients with life threatening conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary outcome was to assess the validity of the STUMBL score for all complications of chest blunt trauma, originally defined by the STUMBL authors
Time Frame: 7 days

These complications include:

  • In-hospital mortality.
  • All pulmonary complications (including but not restricted to haemothorax, pneumothorax, lung contusion, pneumonia, and empyema, excluding rib fractures).
  • Need for ICU admission.
  • Prolonged hospital stay defined as a total hospital stay of 7 days or more
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary outcomes validated the STUMBL score using a composite of early and delayed complications.
Time Frame: 72 hours

Early complications:

  • Presence of a pulmonary complication on arrival to ED as defined above
  • Admission to ICU from ED

Delayed complications:

  • Delayed pulmonary complications defined as pulmonary complications developing or discovered after discharge from the ED to the ward or community,including lung contusion,pleural effusion,empyema, hemothorax,pneumothorax,pneumomediastinum,pneumonia or pulmonary embolism.
  • Delayed escalation in care,defined as a requirement for ICU admission because of chest trauma related complications at any point after discharge from the ED to the ward or community.
  • Unplanned re-presentation to the ED,Patient discharged from ED on the first presentation but re-presented to ED with complications of chest trauma that was not a planned followup assessment within 72h of discharge for patients whose initial hospital stay was 1day or less (including those discharged directly from ED and those admitted to a ward for less than 2days).
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

March 31, 2026

Study Completion (Estimated)

April 30, 2026

Study Registration Dates

First Submitted

March 3, 2024

First Submitted That Met QC Criteria

March 14, 2024

First Posted (Actual)

March 18, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2024

Last Update Submitted That Met QC Criteria

March 26, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUMBL blunt chest trauma

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blunt Injury of Thorax

Subscribe